ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Shin Poong Pharmaceutical Co. Ltd. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 27 studies whose lead sponsor is Shin Poong Pharmaceutical Co. Ltd. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 28, 2025.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Shin Poong Pharmaceutical with Yuhan and Shenzhen Salubris Pharmaceuticals →

Pipeline: 6 programs

Each counted once: 6 with a study Shin Poong Pharmaceutical Co. Ltd. leads registered in the last two years.

  • Phase 2

5 from the earlier phases, besides the phase-3 view.

Program
SPC 2002Phase 2 · 1 live · Essential Hypertension☆ Track
SPC 2003Phase 2 · 1 live · Essential Hypertension☆ Track
SPC 2004Phase 2 · 1 live · Essential Hypertension☆ Track
SPC 5002Phase 2 · 1 live · Hypertension☆ Track
SPC5003Phase 2 · 1 live · Hypertension☆ Track

1 more — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Shin Poong Pharmaceutical Co. Ltd.’s own registered studies; Shin Poong Pharmaceutical Co. Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Shin Poong Pharmaceutical Co. Ltd.’s studies test, most open studies first — 11 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 1 more

Coming up

1 of Shin Poong Pharmaceutical Co. Ltd.’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 27 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now311%Recruiting 2 · Enrolling by invitation 1
  • Under way, not recruiting14%
  • Completed2074%
  • Stopped early14%
  • Status unknown or other27%

Phase

  • Phase 211
  • Phase 36
  • Phase 15
  • Phase 41

Where

  • Korea, Republic of21
  • United Kingdom3
  • Chile1
  • Zambia1
  • Philippines1
  • Argentina1

Over the years

  1. 10
  2. 11
  3. 12
  4. 13
  5. 14
  6. 15
  7. 16
  8. 17
  9. 18
  10. 19
  11. 20
  12. 421
  13. 22
  14. 23
  15. 24
  16. 25
  17. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Shin Poong Pharmaceutical Co. Ltd.

  • Shin Poong Pharmaceutical Co. Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    27 studies

Studies

Recruiting first, then most recently updated. Showing 27 of 27.